News

Cardinal Health Boosts Fiscal 2026 Forecast and Strategic Initiatives

Cardinal Health Boosts Fiscal 2026 Forecast and Strategic Initiatives

Cardinal Health Boosts Fiscal 2026 Forecast and Strategic Initiatives

Cardinal Health has announced an increase in its financial projections for fiscal year 2026. The company is now predicting non-GAAP diluted earnings per share (EPS) to reach at least $10.00, up from the previous guidance of $9.65 to $9.85. This positive adjustment showcases the company's confidence in its performance and strategic direction.

Robust Specialty Growth Ahead

In a significant prediction, Cardinal Health anticipates its Specialty revenues will exceed $50 billion in fiscal 2026. This is expected to reflect a remarkable 16% compounded annual growth rate (CAGR) over the next three years. Such growth can be attributed to an increasing demand for specialty distribution, the expansion of its Managed Services Organization (MSO) platforms, and project robust growth within its BioPharma Solutions sector.

BioPharma Solutions Initiatives

Highlighting success within its BioPharma Solutions division, Cardinal Health points to the achievements of its Sonexus™ Access and Patient Support business. Recently, several leading manufacturers have chosen Sonexus™ for their patient support programs, collectively helping over 1 million patients manage their health more effectively. Notably, this includes a transition of the Dupixent My Way patient support program for Sanofi and Regeneron.

The advancements stem from Cardinal Health's strategic investments in innovation and technology aimed at enhancing the patient support experience through digital solutions.

Adapting to Regulatory Changes

Cardinal Health successfully adjusted its manufacturer distribution service agreements in light of the changes brought about by the 2026 Medicare Drug Price Negotiation Program. This timely transition ensures that the company can continue to fulfill its crucial roles in the healthcare supply chain while navigating new regulatory landscapes.

The company has expressed confidence that it will be compensated fairly for its essential services, which ensure the secure and efficient delivery of pharmaceuticals to customers.

Launch of ContinuCare™ Pathway

Taking steps to enhance patient care, Cardinal Health's at-Home Solutions division has rolled out the ContinuCare™ Pathway program. This innovative initiative aims to simplify the management of diabetes supplies while further integrating resources from its Advanced Diabetes Supply acquisition.

Partnership with Publix Super Markets

The ContinuCare™ Pathway is designed to assist pharmacies and patients in navigating complex insurance processes, particularly for direct home delivery of diabetes supplies covered under medical benefits. Publix Super Markets Inc. has enrolled its entire pharmacy network in this program, significantly expanding its reach to over 11,000 retail pharmacies.

This partnership illustrates Cardinal Health's commitment to enhancing patient outcomes through accessible and efficient healthcare solutions.

Upcoming Investor Events

Cardinal Health plans to share more insightful details during the ongoing J.P. Morgan Healthcare Conference, with presentations scheduled to begin shortly. Investors and market watchers are encouraged to tune in for updates on the company's strategic progress.

About Cardinal Health

Cardinal Health is a leading distributor of pharmaceuticals and specialty products, a global manufacturer, and distributor of medical and laboratory products. The company also manages home-health products and services while providing comprehensive performance solutions driven by a customer-centric focus.

Frequently Asked Questions

What is the new EPS forecast for Cardinal Health in fiscal 2026?

The company has raised its EPS forecast to at least $10.00 for fiscal 2026.

What revenue growth is expected in Cardinal Health's Specialty sector?

The company anticipates Specialty revenues will exceed $50 billion, reflecting a 16% CAGR over three years.

How is Cardinal Health adapting to regulatory changes?

Cardinal Health has successfully transitioned its distribution service agreements in response to the 2026 Medicare Drug Price Negotiation Program.

What is the ContinuCare™ Pathway program offered by Cardinal Health?

This is an innovative program launched to simplify diabetes supply management for pharmacies and patients, providing efficient home delivery options.

How is Cardinal Health supporting its BioPharma Solutions division?

The company has made strategic investments in product innovation and technology to enhance patient support through its Sonexus™ business.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

IDrive's L2+ Driving Tech: The New Industry Sweet Spot

Updated Category News Views 12

Shifting Gears: IDrive's Vision for Tomorrow's Roads There's a seismic shift happening in the automotive world's quest for autonomy, and IDrive's latest announcement is like a jolt of lightning down the highway. Aug. 28, 2026, marks IDrive unveiling a new low-cost, licenseable driving assist platform they claim hits the industry 'sweet spot'. A bold claim, but it's got...

Continue Reading
Countdown to CobbleStone's 2026 User Conference Begins

Updated Category News Views 7

Counting Down to CobbleStone's Big Event Time is dwindling away like sand in an hourglass, with just under a month left for the contract wizards to mark their calendars for the CobbleStone User Conference 2026—a gathering designed to bring breakthroughs, best practices, and a bit of legal wizardry to those reining in contract chaos. Scheduled from October 18 to 20 in...

Continue Reading
Arctech Pushes Renewable Boundaries in Latin America

Updated Category News Views 7

Charting New Terrain in Solar Energy Ever found yourself looking at solar panels and wondering what goes into making them work on those precarious mountain slopes, or in unpredictable climates? Latin America's diverse landscapes call for some serious innovation, and that's where Arctech steps in. This ain't just another company pitching solar panels. Nope. Arctech's...

Continue Reading
Bamboo Insurance Eyes IPO in a Striking Market Move

Updated Category News Views 6

The buzz about Bamboo Insurance is palpable, and it's not just about some random paperwork. This outfit from Midvale, Utah, just filed for a potential IPO. They're eyeing the NYSE under the ticker 'BMB'. The exact number of shares and the price range are still up in the air, but the popcorn's popping as investors are on edge waiting for the next course of action. Gearing...

Continue Reading
INTCO Medical Surges Ahead with 40.6% Revenue Boost

Updated Category News Views 6

Eying Growth: INTCO Medical's Impressive Revenue Surge In today's corporate world, a 40.6% revenue jump over a single half-year isn't something to sneeze at. INTCO Medical, a heavyweight in the disposable glove industry, has done exactly that. The whispers out of Zibo, China, hint at a company that’s firing on all cylinders with $1.03 billion in their pockets for the...

Continue Reading
Bullish Backs USD.AI with $100M for GPU Revolution

Updated Category News Views 9

A New Wave in Digital Asset Financing Kicking open the stablecoin floodgates with a hefty $100 million, Bullish is storming into the middle-market AI infrastructure scene like a freight train. This isn’t your run-of-the-mill financing move. They're laying down serious liquidity groundwork to prop up USD.AI’s GPU financing operations, effectively turning compute into a...

Continue Reading
Americas Cardroom's $50M Poker Spectacle: A Closer Look

Updated Category News Views 5

High-Stakes Heaven: The OSS XL Breakdown If you're into the high drama of poker, Amerias Cardroom is rolling out a real heavy hitter here. A 24-day stamina test of sorts, the Online Super Series XL boasts 336 events with over $50 million in guaranteed prizes. It's poker nirvana from Sept. 6-29. Main Event Madness This saga of risk and reward is anchored by three Main...

Continue Reading
Pharmacists' New Role in Primary Health: Sector Insight

Updated Category News Views 9

Why Elevating Pharmacists Matters Now The winds of change are blowing through the hallowed halls of healthcare, and the stage is set for pharmacists to take a critical role in primary care. With global pharmacy leaders sounding the call, the integration of pharmacists into the primary care framework is getting more spotlight than ever. But let's cut the fluff—what does...

Continue Reading
Liberty Restoration's Bold Midwest Expansion Continues

Updated Category News Views 13

Another Piece in the Puzzle It's one thing to talk ambitious expansion plans, but Liberty Restoration Group ain't messing around—adding new territory like it's a weekend spree at a flea market. They've just snagged ServiceMaster of Columbia and ServiceMaster Restoration Services by KRS. This move ain't small potatoes for any shot caller out there. Growing the Empire...

Continue Reading
EquipmentShare Lawsuit: Investor Deadline Approaches

Updated Category News Views 3

Pressure Mounts in EquipmentShare Legal Drama It’s a sticky situation for EquipmentShare.com, Inc. (NASDAQ:EQPT), and the sands of time aren't on their side. Investors who’ve suffered significant losses from their January IPO debacle are staring down a closing window to step up as a lead plaintiff in a class action lawsuit. The heart of the matter? Allegations of...

Continue Reading

Top 5 Most Recently Viewed Articles

OSI Systems Secures Major $26 Million Contract for Security

Updated Category News Views 66

OSI Systems Lands $26 Million Contract OSI Systems, Inc. (NASDAQ: OSIS) has secured a significant $26 million contract focused on enhancing security operations. This agreement will provide essential maintenance and training services for cargo and vehicle inspection systems used at important ports and border checkpoints. It underscores OSI Systems' dedication to delivering...

Continue Reading
OKX Introduces xBTC on Aptos: Revolutionizing Bitcoin DeFi Use

Updated Category News Views 287

OKX's xBTC Revolutionizes Bitcoin in DeFi Applications xBTC represents a significant advancement for users on the Aptos network, allowing them to engage with a wrapped version of Bitcoin that is fully backed by OKX's BTC reserves without incurring minting or redemption fees. This innovative approach positions xBTC as an essential tool for enhancing the utility of Bitcoin...

Continue Reading
Descartes Expands Logistics Solutions with MyCarrierPortal Buyout

Updated Category News Views 273

Descartes Acquires MyCarrierPortal to Boost Logistics Services Integrating Carrier Onboarding and Risk Monitoring Solutions into the Global Logistics Network Descartes Systems Group (TSX:DSG) (NASDAQ:DSGX), a prominent player in logistics solutions, has taken a major step by acquiring Assure Assist, Inc., which operates as MyCarrierPortal (MCP). This acquisition is...

Continue Reading
Strategic Investment Boosts Absci's AI Drug Development Efforts

Updated Category News Views 120

Absci Corporation and AMD Collaboration Absci Corporation (NASDAQ: ABSI), a leading company in AI-driven drug discovery, has seen its stock soar in premarket trading recently. This surge follows an announcement of a strategic collaboration with Advanced Micro Devices Inc (NASDAQ: AMD) aimed at significantly enhancing AI drug discovery capabilities. Investment and...

Continue Reading
Ameris Bancorp's Commitment to Shareholders: Dividend Insights

Updated Category News Views 48

Ameris Bancorp Announces Quarterly Dividend ATLANTA - Ameris Bancorp (NYSE: ABCB), the parent company of Ameris Bank, has just shared the news of approving a quarterly dividend for its shareholders. The company plans to pay out a dividend of $0.15 per share to those who are shareholders of record by the specified cutoff date. This move reflects the company's commitment to...

Continue Reading